AAstraZeneca Read More New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast CancerJune 25, 2026 The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for…
